Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property Neutral

Health Logic Enters Into Letter Agreement With Better Butchers In Respect Of A Proposed Reverse Takeover

Health Logic Shell Flip to Better Butchers Raises $3.75M Amidst 94% Dilution Risk for Existing Shareholders

By The Northwire Desk — AI Analysis May 11, 2026 · 19:15 CHIP · 0.035
Executive Summary
  • Health Logic Interactive Inc. has entered into a Letter of Intent (LOI) with The Better Butchers Inc. regarding a proposed Reverse Takeover (RTO).
  • Transaction structure involves a three-cornered amalgamation where Health Logic acquires all shares of Better Butchers in exchange for newly issued common shares.
  • Post-transaction, current Health Logic shareholders will retain approximately 6.2% to 7.2% ownership depending on financing size.
  • Concurrent financings are planned totaling between $2.0 million and $3.0 million at $0.15 per share, plus a seed share private placement of $750,000 at $0.10 per share.
  • Total capital raised is estimated between $2.75 million and $3.75 million.
  • Health Logic shares will be consolidated on a 2.5:1 basis, and the company name will change to "The Better Butchers Inc."
  • The resulting issuer will assume approximately $387,000 of debt owed to arm's length creditors, converted into shares at $0.15 per share.
  • Management changes include Mitchell Scott (Better Butchers CEO) becoming CEO/President/Director and Sean Choi as CFO/Corporate Secretary.
  • Definitive agreement expected by October 31, 2026.
  • Listing change involves delisting from NEX and seeking new listing on the Canadian Securities Exchange (CSE).
Material Impact
  • The transaction represents a significant structural shift for Health Logic, effectively converting it into an operating company in the alternative protein sector via Better Butchers.
  • For existing Health Logic shareholders, the dilution is extreme; equity ownership drops to roughly 6% of the new entity, which typically exerts downward pressure on shell stock value unless the target asset is significantly undervalued.
  • The financing component ($2.75M-$3.75M) provides immediate working capital but at a price point ($0.15) that suggests potential distress or aggressive valuation of the new entity.
  • Debt conversion at the same price as the concurrent financing ($0.15/share) indicates creditors are being treated similarly to equity investors, which may signal liquidity concerns for Better Butchers prior to this deal.
  • As an LOI stage transaction with a definitive agreement deadline in October 2026, there is execution risk; the deal could fail or terms could change before closing.
  • The move from NEX to CSE listing indicates a desire for higher visibility but does not guarantee liquidity improvement immediately.
  • Given the lack of historical context on Health Logic's prior performance and the speculative nature of RTOs in small caps, this is categorized as Routine - Neutral until definitive agreement terms are locked.
CHIP · Price
Company Overview
  • Current Entity: Health Logic Interactive Inc., currently listed on NEX, acting as a shell vehicle for the transaction.
  • Target Entity: The Better Butchers Inc., an operating company in the alternative protein category.
  • Flagship Project: Better Butchers' business operations in the alternative protein sector, claiming product-market fit and a combined market opportunity exceeding US$133 billion across North America and Europe.
  • Development Stage: Better Butchers appears to be at a commercialization or early growth stage given the claim of "product-market fit" and need for working capital financing.
Read the original news release →